CASI PHARMACEUTICALS INC - COM (CASI)

CUSIP: 14757U109

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COM
Total 13F shares
39,599,236
Share change
+16,709,871
Total reported value
$60,588,863
Price per share
$1.53
Number of holders
64
Value change
+$25,462,661
Number of buys
35
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 14757U109?
CUSIP 14757U109 identifies CASI - CASI PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASI PHARMACEUTICALS INC - COM (CASI) as of Q3 2020

As of 30 Sep 2020, CASI PHARMACEUTICALS INC - COM (CASI) was held by 64 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,599,236 shares. The largest 10 holders included IDG-Accel China Growth Fund III Associates L.P., FEDERATED HERMES, INC., Consonance Capital Management LP, BlackRock Inc., VANGUARD GROUP INC, Ikarian Capital, LLC, Wellington Shields & Co., LLC, Wellington Shields Capital Management, LLC, STATE STREET CORP, and NORTHERN TRUST CORP. This page lists 64 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.